ILMN on XNAS, Technology, Illumina Inc, job postings
Measures activity, not value. Not investment advice.
Insiders sold $270.2M in 90 days while shares fell 32% in a month, still up 62% in a year.
BadShort interest 10.6M shares, 1.4 times a year earlier
GoodNew institutional positions 245, 2.6 times a year earlier
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 27 Sep 2026
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
expected around 12 Jan 2027 (an estimate: a year ago it reported on 13 Jan 2026)
Revenue and net income per quarter. Quarter to 27 Sep 2026: revenue $1.1B, net income $220.0M.
2 Jan 2022RevenueNet incomeNet losstallest bar $3.8B27 Sep 2026
See the numbers
Quarter to
Revenue
Net income
27 Sep 2026
$1.1B
$220.0M
28 Jun 2026
$1.2B
$207.0M
29 Mar 2026
$1.1B
$134.0M
28 Dec 2025
$1.2B
$334.0M
28 Sep 2025
$1.1B
$150.0M
29 Jun 2025
$1.1B
$235.0M
30 Mar 2025
$1.0B
$131.0M
29 Dec 2024
$1.1B
$186.0M
29 Sep 2024
$1.1B
$705.0M
30 Jun 2024
$1.1B
-$2.0B
31 Mar 2024
$1.1B
-$126.0M
31 Dec 2023
$1.1B
-$176.0M
1 Oct 2023
$1.1B
-$754.0M
2 Jul 2023
$1.2B
-$234.0M
2 Apr 2023
$1.1B
$3.0M
1 Jan 2023
$1.1B
-$139.0M
2 Oct 2022
$1.1B
-$3.8B
3 Jul 2022
$1.2B
-$535.0M
3 Apr 2022
$1.2B
$86.0M
2 Jan 2022
$1.2B
$113.0M
Fundamentals, 12 months to 27 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$4.5B
$4.3B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+5.8%
+5.0%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$895.0M
$702.0M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$5.81
$4.46
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
67.9%
66.2%
49.6%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
21.2%
18.2%
-7.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
19.7%
16.4%
-10.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
32.4%
-17.0%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$1.1B
$1.0B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$1.3B
$1.3B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$1.8B
$2.0B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$452.0M
$714.0M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.57
0.45
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$20.80
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
32.6
33.4
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
6.4
4.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
6.5
4.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
9.3
2.4
Latest = 12 months to 27 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$270.2M
bought $0, sold $270.2M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+20%
1,100 13F filers vs 918
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
160.5M shares held by 13F filers (30 Sep 2026) of 151.2M outstanding (23 Oct 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
5.3%
8.0M shares sold short (30 Oct 2026) of 151.2M outstanding (23 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
3.7
8.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+1.7%
7.9M shares sold short in the report before, 8.0M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
65%
65% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 61%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-26%
84 vs 114 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+4.2%
$1.1B vs $1.1B (quarter ended 27 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+29%
$40.0M vs $31.0M (quarter ended 27 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$32.9M
the 12 months before: $31.6M
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$1.2M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
58
58 articles in the last 7 days; its usual week has 7.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
7.7×
58 articles in the last 7 days; its usual week has 7.5.
Unusual now sharp changes in the last 90 days, compared with its own past
New institutional positions 245, 2.6× a year earlier
Short interest 10.6M, 1.4× a year earlier
Price $192.82 on 20 Nov 2026, +62% over 12 months (12-month range $114.44 to $293.69)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $720.6M in the last 12 months (the 12 months before: $1.6M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 84 published in the last 12 months, -26% on the 12 months before.Revenue per quarter. Revenue $1.1B in the latest quarter, +4.2% on a year earlier.Capital spending per quarter. Capital spending $40.0M in the latest quarter, +29% on a year earlier.Institutional holders (13F filers). 1,100 13F filers reported holding it in the latest 13F quarter, +51% on a year earlier.Federal obligations. Federal obligations: $27.0M published in the last 12 months, -16% on the 12 months before.Lobbying spend. Lobbying spend: $1.2M published in the last 12 months, -41% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 2 Jan 2022: $1.2B, +26% on a year earlier; public on 19 Feb 2022
Quarter ended 3 Apr 2022: $1.2B, +12% on a year earlier; public on 6 May 2022
Quarter ended 3 Jul 2022: $1.2B, +3.2% on a year earlier; public on 12 Aug 2022
Quarter ended 2 Oct 2022: $1.1B, +0.6% on a year earlier; public on 5 Nov 2022
Quarter ended 1 Jan 2023: $1.1B, -9.7% on a year earlier; public on 18 Feb 2023
Quarter ended 2 Apr 2023: $1.1B, -11% on a year earlier; public on 6 May 2023
Quarter ended 2 Jul 2023: $1.2B, +1.2% on a year earlier; public on 11 Aug 2023
Quarter ended 1 Oct 2023: $1.1B, +0.4% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $1.1B, +3.6% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $1.1B, -1.0% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $1.1B, -5.4% on a year earlier; public on 8 Aug 2024
Quarter ended 29 Sep 2024: $1.1B, -3.5% on a year earlier; public on 7 Nov 2024
Quarter ended 29 Dec 2024: $1.1B, -1.6% on a year earlier; public on 13 Feb 2025
Quarter ended 30 Mar 2025: $1.0B, -3.3% on a year earlier; public on 10 May 2025
Quarter ended 29 Jun 2025: $1.1B, -4.8% on a year earlier; public on 2 Aug 2025
Quarter ended 28 Sep 2025: $1.1B, +0.4% on a year earlier; public on 1 Nov 2025
Quarter ended 28 Dec 2025: $1.2B, +5.0% on a year earlier; public on 13 Feb 2026
Quarter ended 29 Mar 2026: $1.1B, +4.8% on a year earlier; public on 5 May 2026
Quarter ended 28 Jun 2026: $1.2B, +9.4% on a year earlier; public on 1 Aug 2026
Quarter ended 27 Sep 2026: $1.1B, +4.2% on a year earlier; public on 31 Oct 2026
Capital spending per quarter
Quarter ended 2 Jan 2022: $70.0M, +13% on a year earlier; public on 19 Feb 2022
Quarter ended 3 Apr 2022: $61.0M, +45% on a year earlier; public on 6 May 2022
Quarter ended 3 Jul 2022: $71.0M, +61% on a year earlier; public on 12 Aug 2022
Quarter ended 2 Oct 2022: $66.0M, +27% on a year earlier; public on 5 Nov 2022
Quarter ended 1 Jan 2023: $88.0M, +26% on a year earlier; public on 18 Feb 2023
Quarter ended 2 Apr 2023: $52.0M, -15% on a year earlier; public on 6 May 2023
Quarter ended 2 Jul 2023: $47.0M, -34% on a year earlier; public on 11 Aug 2023
Quarter ended 1 Oct 2023: $45.0M, -32% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $51.0M, -42% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $36.0M, -31% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $31.0M, -34% on a year earlier; public on 8 Aug 2024
Quarter ended 29 Sep 2024: $32.0M, -29% on a year earlier; public on 7 Nov 2024
Quarter ended 29 Dec 2024: $29.0M, -43% on a year earlier; public on 13 Feb 2025
Quarter ended 30 Mar 2025: $32.0M, -11% on a year earlier; public on 10 May 2025
Quarter ended 29 Jun 2025: $30.0M, -3.2% on a year earlier; public on 2 Aug 2025
Quarter ended 28 Sep 2025: $31.0M, -3.1% on a year earlier; public on 1 Nov 2025
Quarter ended 28 Dec 2025: $55.0M, +90% on a year earlier; public on 13 Feb 2026
Quarter ended 29 Mar 2026: $38.0M, +19% on a year earlier; public on 5 May 2026
Quarter ended 28 Jun 2026: $40.0M, +33% on a year earlier; public on 1 Aug 2026
Quarter ended 27 Sep 2026: $40.0M, +29% on a year earlier; public on 31 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 946; public on 14 Feb 2022
31 Mar 2022 report: 960; public on 16 May 2022
30 Jun 2022 report: 845; public on 15 Aug 2022
30 Sep 2022 report: 820; public on 14 Nov 2022
31 Dec 2022 report: 853; public on 14 Feb 2023
31 Mar 2023 report: 875; public on 15 May 2023
30 Jun 2023 report: 811; public on 14 Aug 2023
30 Sep 2023 report: 749; public on 14 Nov 2023
31 Dec 2023 report: 751; public on 14 Feb 2024
31 Mar 2024 report: 748; public on 15 May 2024
30 Jun 2024 report: 728; public on 14 Aug 2024
30 Sep 2024 report: 757; public on 14 Nov 2024
31 Dec 2024 report: 814; public on 14 Feb 2025
31 Mar 2025 report: 689; public on 15 May 2025
30 Jun 2025 report: 708; public on 14 Aug 2025
30 Sep 2025 report: 728; public on 14 Nov 2025
31 Dec 2025 report: 820; public on 17 Feb 2026
31 Mar 2026 report: 823; public on 15 May 2026
30 Jun 2026 report: 918; public on 14 Aug 2026
30 Sep 2026 report: 1,100; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $2.4M published
Month from 1 Dec 2021: $10.7M published
Month from 1 Jan 2022: $1.3M published
Month from 1 Feb 2022: $1.4M published
Month from 1 Mar 2022: $2.9M published
Month from 1 Apr 2022: $1.8M published
Month from 1 May 2022: $4.4M published
Month from 1 Jun 2022: $2.7M published
Month from 1 Jul 2022: $3.7M published
Month from 1 Aug 2022: $4.7M published
Month from 1 Sep 2022: $8.1M published
Month from 1 Oct 2022: $1.6M published
Month from 1 Nov 2022: $3.6M published
Month from 1 Dec 2022: $5.2M published
Month from 1 Jan 2023: $854K published
Month from 1 Feb 2023: $2.7M published
Month from 1 Mar 2023: $2.7M published
Month from 1 Apr 2023: $2.1M published
Month from 1 May 2023: $5.5M published
Month from 1 Jun 2023: $3.3M published
Month from 1 Jul 2023: $3.7M published
Month from 1 Aug 2023: $3.7M published
Month from 1 Sep 2023: $12.9M published
Month from 1 Oct 2023: $1.5M published
Month from 1 Nov 2023: $4.1M published
Month from 1 Dec 2023: $2.3M published
Month from 1 Jan 2024: $1.7M published
Month from 1 Feb 2024: $1.7M published
Month from 1 Mar 2024: $2.0M published
Month from 1 Apr 2024: $2.4M published
Month from 1 May 2024: $2.2M published
Month from 1 Jun 2024: $2.2M published
Month from 1 Jul 2024: $3.7M published
Month from 1 Aug 2024: $5.8M published
Month from 1 Sep 2024: $6.4M published
Month from 1 Oct 2024: $1.5M published
Month from 1 Nov 2024: $2.8M published
Month from 1 Dec 2024: $3.7M published
Month from 1 Jan 2025: $1.1M published
Month from 1 Feb 2025: $657K published
Month from 1 Mar 2025: $3.0M published
Month from 1 Apr 2025: $1.0M published
Month from 1 May 2025: $1.1M published
Month from 1 Jun 2025: $2.1M published
Month from 1 Jul 2025: $3.3M published
Month from 1 Aug 2025: $4.4M published
Month from 1 Sep 2025: $8.3M published
Month from 1 Oct 2025: $3.2M published
Month from 1 Nov 2025: $180K published
Month from 1 Dec 2025: $2.8M published
Month from 1 Jan 2026: $359K published
Month from 1 Feb 2026: $1.3M published
Month from 1 Mar 2026: $2.1M published
Month from 1 Apr 2026: $1.7M published
Month from 1 May 2026: $2.7M published
Month from 1 Jun 2026: $2.3M published
Month from 1 Jul 2026: $2.1M published
Month from 1 Aug 2026: $4.5M published
Month from 1 Sep 2026: $4.7M published
Month from 1 Oct 2026: $2.0M published
Month from 1 Nov 2026: $378K published
Lobbying spend
Quarter from 1 Jan 2022: $1.4M published
Quarter from 1 Apr 2022: $2.1M published
Quarter from 1 Jul 2022: $1.8M published
Quarter from 1 Oct 2022: $1.5M published
Quarter from 1 Jan 2023: $1.4M published
Quarter from 1 Apr 2023: $1.3M published
Quarter from 1 Jul 2023: $1.6M published
Quarter from 1 Oct 2023: $440K published
Quarter from 1 Jan 2024: $510K published
Quarter from 1 Apr 2024: $380K published
Quarter from 1 Jul 2024: $270K published
Quarter from 1 Oct 2024: $300K published
Quarter from 1 Jan 2025: $450K published
Quarter from 1 Apr 2025: $670K published
Quarter from 1 Jul 2025: $460K published
Quarter from 1 Oct 2025: $430K published
Quarter from 1 Jan 2026: $330K published
Quarter from 1 Apr 2026: $320K published
Quarter from 1 Jul 2026: $300K published
Quarter from 1 Oct 2026: $240K published
What is unusual now
Made public in the last 90 days: it saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year; it also had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year.
Many funds opening a new position: saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year Public on 16 Nov 2026.
Short interest spike: had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year Public on 25 Sep 2026.
In 12 months: 3 director or officer changes, 2 major agreements, 1 completed deal, 1 agreement ended. Results releases and routine reports are left out.
Filed
What happened
Source
13 Oct 2026
Signed a major agreementSame filing: took on new debt
Reported lobbying spend: $240K in Q3 2026, $300K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Apr 2026
New
Thorn Run Partnersfor Illumina, Inc.
FY27 House LHHS & Senate Defense Appropriations in relation to proteomics research.Budget
Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies.; Issues and legislation related to tax reform and corporate tax policy; General discussion and monitoring of U.S. trade policyHealth issues, Taxation, Trade
Issues related to S. 3558 - A bill to prohibit contracting with certain biotechnology providers, and for other purposes.Health issues, Homeland security
Two or more unrelated kinds of records unusual within 30 days
19 Nov 2024confirmed
Confirmed across sources Institutional holdings and Short interest and volume
Illumina(ILMN): saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year, while it had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year. Two unrelated kinds of activity within 49 days.
Short interest and volume: Short interest spike, became public on 25 Oct 2024
Institutional holdings: Many funds opening a new position, became public on 14 Nov 2024
Short interest and volume: Short interest spike, became public on 13 Nov 2024
Short interest and volume: Short interest spike, became public on 11 Dec 2024
The quarter ended 30 Sep 2024 against the 8 quarters before it.
this quarterearliernormal: 87See the evidence (4 changes)
Short interest and volume: Short interest spike became public on 25 Oct 2024
Illumina had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.
This period
6.8M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.6
Same report last year
5.5M
History used
2,482 days
the 15 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Nov 2024
Illumina saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.
This period
124 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
87
Typical spread (median absolute deviation)
5.5
How far from its usual level
+4.3
Same quarter last year
58
History used
4,018 days
the quarter ended 30 Sep 20248 earlier quartersnormal: 87
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 13 Nov 2024
Illumina had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.
This period
6.7M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.5
Same report last year
5.2M
History used
2,498 days
the 31 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Dec 2024
Illumina had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.
This period
7.2M (the 29 Nov 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
312K
How far from its usual level
+4.5
Same report last year
5.0M
History used
2,527 days
the 29 Nov 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
26 Jul 2022confirmed
Confirmed across sources Hiring and Lobbying and Short interest and volume
Illumina(ILMN): reported $1.8M of lobbying spend for the quarter ended 30 Jun 2022, 5.1× the same quarter last year; it also had 40 H-1B/E-3 visa applications certified in May 2022, 3.6× the same month last year; and it had 5.0M shares sold short in the 14 Oct 2022 report, 2.7× the same report last year. Three unrelated kinds of activity within 154 days.
Short interest and volume: Short interest spike, became public on 28 Jun 2022
Short interest and volume: Short interest spike, became public on 13 Jul 2022
Lobbying: Lobbying spend jump, became public on 19 Jul 2022
Short interest and volume: Short interest spike, became public on 27 Jul 2022
Short interest and volume: Short interest spike, became public on 25 Aug 2022
Short interest and volume: Short interest spike, became public on 13 Sep 2022
Short interest and volume: Short interest spike, became public on 27 Sep 2022
Hiring: H-1B/E-3 applications change, became public on 28 Sep 2022
Short interest and volume: Short interest spike, became public on 13 Oct 2022
Short interest and volume: Short interest spike, became public on 26 Oct 2022
Short interest and volume: Short interest spike, became public on 10 Nov 2022
Short interest and volume: Short interest spike, became public on 26 Nov 2022
The quarter ended 30 Jun 2022 against the 8 quarters before it.
this quarterearliernormal: $350KSee the evidence (12 changes)
Short interest and volume: Short interest spike became public on 28 Jun 2022
Illumina had 3.4M shares sold short in the 15 Jun 2022 report, 1.3× the same report last year.
This period
3.4M (the 15 Jun 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.2
Same report last year
2.7M
History used
1,629 days
the 15 Jun 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 13 Jul 2022
Illumina had 3.9M shares sold short in the 30 Jun 2022 report, 1.5× the same report last year.
This period
3.9M (the 30 Jun 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+5.5
Same report last year
2.6M
History used
1,644 days
the 30 Jun 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying spend jump became public on 19 Jul 2022
Illumina reported $1.8M of lobbying spend for the quarter ended 30 Jun 2022, 5.1× the same quarter last year.
This period
$1.8M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$350K
Typical spread (median absolute deviation)
$95K
How far from its usual level
+10.5
Same quarter last year
$360K
History used
3,468 days
the quarter ended 30 Jun 20228 earlier quartersnormal: $350K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Short interest and volume: Short interest spike became public on 27 Jul 2022
Illumina had 3.6M shares sold short in the 15 Jul 2022 report, 1.5× the same report last year.
This period
3.6M (the 15 Jul 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.6
Same report last year
2.4M
History used
1,659 days
the 15 Jul 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Aug 2022
Illumina had 3.5M shares sold short in the 15 Aug 2022 report, 1.6× the same report last year.
This period
3.5M (the 15 Aug 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.4
Same report last year
2.2M
History used
1,690 days
the 15 Aug 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 13 Sep 2022
Illumina had 4.4M shares sold short in the 31 Aug 2022 report, 2.0× the same report last year.
This period
4.4M (the 31 Aug 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
255K
How far from its usual level
+6.4
Same report last year
2.2M
History used
1,706 days
the 31 Aug 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 27 Sep 2022
Illumina had 4.4M shares sold short in the 15 Sep 2022 report, 1.8× the same report last year.
This period
4.4M (the 15 Sep 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
275K
How far from its usual level
+6.0
Same report last year
2.4M
History used
1,721 days
the 15 Sep 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Hiring: H-1B/E-3 applications change became public on 28 Sep 2022
Illumina had 40 H-1B/E-3 visa applications certified in May 2022, 3.6× the same month last year.
This period
40 (May 2022)
Normal month (median of 2 earlier)
9.5
Typical spread (median absolute deviation)
1.5
How far from its usual level
+10.2
Same month last year
11
History used
973 days
May 20222 earlier monthsnormal: 9.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 13 Oct 2022
Illumina had 4.3M shares sold short in the 30 Sep 2022 report, 2.1× the same report last year.
This period
4.3M (the 30 Sep 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
294K
How far from its usual level
+5.5
Same report last year
2.1M
History used
1,736 days
the 30 Sep 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Oct 2022
Illumina had 5.0M shares sold short in the 14 Oct 2022 report, 2.7× the same report last year.
This period
5.0M (the 14 Oct 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
294K
How far from its usual level
+7.0
Same report last year
1.8M
History used
1,750 days
the 14 Oct 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Nov 2022
Illumina had 4.8M shares sold short in the 31 Oct 2022 report, 2.3× the same report last year.
This period
4.8M (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
322K
How far from its usual level
+6.0
Same report last year
2.1M
History used
1,767 days
the 31 Oct 2022 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Nov 2022
Illumina had 4.4M shares sold short in the 15 Nov 2022 report, 2.5× the same report last year.
This period
4.4M (the 15 Nov 2022 report)
Normal report (median of 24 earlier)
2.0M
Typical spread (median absolute deviation)
444K
How far from its usual level
+3.5
Same report last year
1.7M
History used
1,782 days
the 15 Nov 2022 report24 earlier reportsnormal: 2.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
26 Oct 2021confirmed
Confirmed across sources Government contracts and Lobbying
Illumina(ILMN): won its first award from the Department of Veterans Affairs, a $1.6M contract, after 27 earlier federal awards from other agencies, while it reported $1.5M of lobbying spend for the quarter ended 30 Sep 2021, 4.4× the same quarter last year. Two unrelated kinds of activity within 21 days.
Government contracts: First award from a new federal agency, became public on 5 Oct 2021
Lobbying: Lobbying spend jump, became public on 20 Oct 2021
The quarter ended 30 Sep 2021 against the 8 quarters before it.
this quarterearliernormal: $265KSee the evidence (2 changes)
Government contracts: First award from a new federal agency became public on 5 Oct 2021
Illumina won its first award from the Department of Veterans Affairs, a $1.6M contract, after 27 earlier federal awards from other agencies.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Lobbying: Lobbying spend jump became public on 20 Oct 2021
Illumina reported $1.5M of lobbying spend for the quarter ended 30 Sep 2021, 4.4× the same quarter last year.
This period
$1.5M (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$265K
Typical spread (median absolute deviation)
$80K
How far from its usual level
+10.4
Same quarter last year
$340K
History used
3,195 days
the quarter ended 30 Sep 20218 earlier quartersnormal: $265K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
16 Nov 2026Institutional holdings change
saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year.
Same quarter last year: 96; its normal quarter is 105.
See the evidence
This period
245 (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
105
Typical spread (median absolute deviation)
23
How far from its usual level
+4.1
Same quarter last year
96
History used
4,748 days
the quarter ended 30 Sep 20268 earlier quartersnormal: 105
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year.
Same report last year: 7.3M; its normal report is 7.3M.
See the evidence
This period
10.6M (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
583K
How far from its usual level
+3.8
Same report last year
7.3M
History used
3,182 days
the 15 Sep 2026 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
drew 6,435 Wikipedia page views in the week of 11 May 2026, 4.5× the same week last year.
Same week last year: 1,434; its normal week is 846.
See the evidence
This period
6,435 (the week of 11 May 2026)
Normal week (median of 26 earlier)
846
Typical spread (median absolute deviation)
70
How far from its usual level
+27.9
Same week last year
1,434
History used
2,638 days
the week of 11 May 202626 earlier weeksnormal: 846
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
spent $55.0M on capital projects in the quarter ended 28 Dec 2025, 1.9× the same quarter last year.
Same quarter last year: $29.0M; its normal quarter is $31.5M.
See the evidence
This period
$55.0M (the quarter ended 28 Dec 2025)
Normal quarter (median of 8 earlier)
$31.5M
Typical spread (median absolute deviation)
$1.0M
How far from its usual level
+7.5
Same quarter last year
$29.0M
History used
5,936 days
the quarter ended 28 Dec 20258 earlier quartersnormal: $31.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
drew 5,355 Wikipedia page views in the week of 3 Feb 2025, 3.5× the same week last year.
Same week last year: 1,522; its normal week is 1,291.
See the evidence
This period
5,355 (the week of 3 Feb 2025)
Normal week (median of 26 earlier)
1,291
Typical spread (median absolute deviation)
76.5
How far from its usual level
+20.3
Same week last year
1,522
History used
2,176 days
the week of 3 Feb 202526 earlier weeksnormal: 1,291
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.
Same report last year: 5.0M; its normal report is 5.0M.
See the evidence
This period
7.2M (the 29 Nov 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
312K
How far from its usual level
+4.5
Same report last year
5.0M
History used
2,527 days
the 29 Nov 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year, while it had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year. Two unrelated kinds of activity within 49 days.
See the evidence (4 changes)
Short interest and volume: Short interest spike became public on 25 Oct 2024
Illumina had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.
This period
6.8M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.6
Same report last year
5.5M
History used
2,482 days
the 15 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Nov 2024
Illumina saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.
This period
124 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
87
Typical spread (median absolute deviation)
5.5
How far from its usual level
+4.3
Same quarter last year
58
History used
4,018 days
the quarter ended 30 Sep 20248 earlier quartersnormal: 87
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 13 Nov 2024
Illumina had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.
This period
6.7M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.5
Same report last year
5.2M
History used
2,498 days
the 31 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Dec 2024
Illumina had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.
This period
7.2M (the 29 Nov 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
312K
How far from its usual level
+4.5
Same report last year
5.0M
History used
2,527 days
the 29 Nov 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
14 Nov 2024Institutional holdings change
saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.
Same quarter last year: 58; its normal quarter is 87.
See the evidence
This period
124 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
87
Typical spread (median absolute deviation)
5.5
How far from its usual level
+4.3
Same quarter last year
58
History used
4,018 days
the quarter ended 30 Sep 20248 earlier quartersnormal: 87
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.
Same report last year: 5.2M; its normal report is 5.0M.
See the evidence
This period
6.7M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.5
Same report last year
5.2M
History used
2,498 days
the 31 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.
Same report last year: 5.5M; its normal report is 5.0M.
See the evidence
This period
6.8M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.6
Same report last year
5.5M
History used
2,482 days
the 15 Oct 2024 report24 earlier reportsnormal: 5.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 183 entries; narrow the window or the kind of data to see older ones.
Not listed: 592 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001110803
Ticker
ILMN
Domain
illumina.com
Employer name
fluent biosciences, Illumina, Inc., illumina software, illumina technology solutions and 1 more (5 unverified)
Fein
01-0577067 (1 unverified)
Hq location
CA|SAN DIEGO|92122 (1 unverified)
Lobbying client
actum obo illumina, dla piper llp us on behalf of illumina, illumina, paul hastings llp on behalf of illumina
Name
Advanced Liquid Logic Inc, BlueBee Holding BV, Emedgene Technologies Ltd, Fluent Biosciences Inc and 39 more
Uei
KMW3CRWNAAF3
Wikidata
Q2068984
Wikipedia
Illumina, Inc.
DOL H-1B labor condition applications and PERM certifications1610 data points1 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)33 records, 137 data points20 Nov 2012 to 30 Sep 2026
SEC Form 13F institutional holdings5 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)203 records14 Jan 2016 to 30 Oct 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1331 data points30 Dec 2007 to 23 Oct 2026
SEC Form 4 insider transactions444 records, 1316 data points4 Jan 2016 to 12 Nov 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards35 records, 11898 data points4 Oct 2007 to 20 Nov 2026
Wikipedia pageviews2827 data points25 Feb 2019 to 21 Nov 2026